Insider Trading - Thompson Peter A.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Thompson Peter A.
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-12-29
Sale
2021-12-30
8:55 pm
Janux Therapeutics Inc. JANX Thompson Peter A.
Director
40,400 $20.3 $820,120 231,098
(Indirect)
View
2021-12-21
Sale
2021-12-23
4:08 pm
Janux Therapeutics Inc. JANX Thompson Peter A.
Director
119,400 $19 $2,268,600 234,798
(Indirect)
View
2021-12-16
Sale
2021-12-17
5:16 pm
Janux Therapeutics Inc. JANX Thompson Peter A.
Director
393,300 $19.07 $7,500,231 245,898
(Indirect)
View
2021-09-20
Sale
2021-09-22
5:24 pm
Corvus Pharmaceuticals Inc. CRVS Thompson Peter A.
Director
10% Owner
1,109,644 $6.09 $6,757,732 6,943,654
(Indirect)
View
2021-09-17
Purchase
2021-09-21
6:38 pm
ALPINE IMMUNE SCIENCES Inc ALPN Thompson Peter A.
Director
10% Owner
1,010,637 $9.4 $9,499,988 425,531
(Indirect)
View
2021-06-15
Purchase
2021-06-16
6:20 pm
Janux Therapeutics Inc. JANX Thompson Peter A.
Director
705,853 $17 $11,999,501 282,398
(Indirect)
View
2021-03-30
Purchase
2021-03-31
7:11 pm
Edgewise Therapeutics Inc. EWTX Thompson Peter A.
Director
10% Owner
359,375 $16 $5,750,000 13,359,456
(Indirect)
View
2021-02-17
Purchase
2021-02-19
6:50 pm
Decibel Therapeutics Inc. DBTX Thompson Peter A.
Director
10% Owner
1,666,666 $18 $29,999,988 883,418
(Indirect)
View
2021-02-17
Purchase
2021-02-19
4:47 pm
Corvus Pharmaceuticals Inc. CRVS Thompson Peter A.
Director
10% Owner
1,285,714 $3.5 $4,499,999 8,053,298
(Indirect)
View
2020-12-28
Sale
2020-12-30
4:38 pm
ALPINE IMMUNE SCIENCES Inc ALPN Thompson Peter A.
Director
10% Owner
600,000 $14.25 $8,550,000 3,070,955
(Indirect)
View
2020-12-08
Purchase
2020-12-08
8:43 pm
Silverback Therapeutics Inc. SBTX Thompson Peter A.
Director
10% Owner
1,190,477 $21 $25,000,017 1,221,700
(Indirect)
View
2020-09-25
Purchase
2020-09-29
4:38 pm
PMV Pharmaceuticals Inc. PMVP Thompson Peter A.
Director
10% Owner
950,000 $18 $17,100,000 475,000
(Indirect)
View
2019-08-06
Purchase
2019-08-08
5:00 pm
Corvus Pharmaceuticals Inc. CRVS Thompson Peter A.
Director
10% Owner
142,656 $3.51 $500,723 6,767,584
(Indirect)
View
2019-06-27
Purchase
2019-07-01
6:16 pm
Corvus Pharmaceuticals Inc. CRVS Thompson Peter A.
Director
10% Owner
657,344 $3.7181 $2,444,065 6,624,928
(Indirect)
View
2019-06-24
Purchase
2019-06-26
4:56 pm
Prevail Therapeutics Inc. PRVL Thompson Peter A.
Director
10% Owner
882,352 $17 $14,999,984 13,822,463
(Indirect)
View
2019-01-18
Purchase
2019-01-23
6:01 pm
ALPINE IMMUNE SCIENCES Inc ALPN Thompson Peter A.
Director
10% Owner
372,439 $5.37 $1,999,997 3,816,206
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-01-03
Option Award
2022-01-04
5:19 pm
N/A
2032-01-02
ALPINE IMMUNE SCIENCES Inc ALPN Thompson Peter A.
Director
10% Owner
10,000 $0 10,000
(Direct)
View
2021-06-04
Option Award
2021-09-21
5:14 pm
N/A
2031-06-03
Silverback Therapeutics Inc. SBTX Thompson Peter A.
Director
10% Owner
15,000 $0 15,000
(Direct)
View
2021-09-09
Option Award
2021-09-13
4:53 pm
N/A
2031-09-09
Corvus Pharmaceuticals Inc. CRVS Thompson Peter A.
Director
10% Owner
15,000 $0 8,068,298
(Direct)
View
2021-06-15
Conversion
2021-06-16
6:20 pm
N/A
N/A
Janux Therapeutics Inc. JANX Thompson Peter A.
Director
4,161,198 $0 282,398
(Indirect)
View
2021-06-15
Option Award
2021-06-16
4:15 pm
N/A
2031-06-15
Corvus Pharmaceuticals Inc. CRVS Thompson Peter A.
Director
10% Owner
15,000 $0 8,068,298
(Direct)
View
2021-06-10
Option Award
2021-06-14
5:43 pm
N/A
2031-06-09
Janux Therapeutics Inc. JANX Thompson Peter A.
Director
10% Owner
30,000 $0 30,000
(Direct)
View
2021-06-10
Ownership
2021-06-10
7:22 pm
N/A
N/A
Janux Therapeutics Inc. JANX Thompson Peter A.
Director
0 $0 2,336,911
(Indirect)
View
2021-06-02
Option Award
2021-06-09
5:41 pm
N/A
2031-06-01
PMV Pharmaceuticals Inc. PMVP Thompson Peter A.
Director
10% Owner
16,333 $0 16,333
(Direct)
View
2021-03-30
Conversion
2021-03-31
7:11 pm
N/A
N/A
Edgewise Therapeutics Inc. EWTX Thompson Peter A.
Director
10% Owner
25,732,796 $0 13,359,456
(Indirect)
View
2021-03-25
Ownership
2021-03-25
9:40 pm
N/A
N/A
Edgewise Therapeutics Inc. EWTX Thompson Peter A.
Director
10% Owner
0 $0 13,319,680
(Indirect)
View
2021-02-17
Conversion
2021-02-19
6:50 pm
N/A
N/A
Decibel Therapeutics Inc. DBTX Thompson Peter A.
Director
10% Owner
20,654,719 $0 883,418
(Indirect)
View
2021-02-11
Option Award
2021-02-16
4:50 pm
N/A
2031-02-10
Decibel Therapeutics Inc. DBTX Thompson Peter A.
Director
10% Owner
20,000 $0 20,000
(Direct)
View
2021-02-11
Ownership
2021-02-11
9:10 pm
N/A
N/A
Decibel Therapeutics Inc. DBTX Thompson Peter A.
Director
10% Owner
0 $0 3,278,526
(Indirect)
View
2021-01-22
Equity Swap
2021-01-26
5:05 pm
N/A
N/A
Prevail Therapeutics Inc. PRVL Thompson Peter A.
Director
10% Owner
13,822,463 $0 0
(Indirect)
View
2021-01-22
Disposition
2021-01-26
5:05 pm
N/A
N/A
Prevail Therapeutics Inc. PRVL Thompson Peter A.
Director
10% Owner
17,000 $0 0
(Direct)
View
2021-01-04
Option Award
2021-01-05
7:00 pm
N/A
2031-01-03
ALPINE IMMUNE SCIENCES Inc ALPN Thompson Peter A.
Director
10% Owner
7,650 $0 7,650
(Direct)
View
2020-12-08
Conversion
2020-12-08
8:43 pm
N/A
N/A
Silverback Therapeutics Inc. SBTX Thompson Peter A.
Director
10% Owner
33,046,445 $0 1,221,700
(Indirect)
View
2020-12-03
Option Award
2020-12-07
8:02 pm
N/A
2030-12-02
Silverback Therapeutics Inc. SBTX Thompson Peter A.
Director
10% Owner
38,270 $0 38,270
(Direct)
View
2020-12-03
Ownership
2020-12-03
8:59 pm
N/A
N/A
Silverback Therapeutics Inc. SBTX Thompson Peter A.
Director
10% Owner
0 $0 7,550,411
(Indirect)
View
2020-09-25
Conversion
2020-09-29
4:38 pm
N/A
N/A
PMV Pharmaceuticals Inc. PMVP Thompson Peter A.
Director
10% Owner
6,114,330 $0 475,000
(Indirect)
View
2020-09-24
Ownership
2020-09-24
7:17 pm
N/A
N/A
PMV Pharmaceuticals Inc. PMVP Thompson Peter A.
Director
10% Owner
0 $0 6,114,330
(Indirect)
View
2020-06-17
Option Award
2020-06-19
6:40 pm
N/A
2030-06-17
Prevail Therapeutics Inc. PRVL Thompson Peter A.
Director
10% Owner
17,000 $0 17,000
(Direct)
View
2020-06-09
Option Award
2020-06-12
5:15 pm
N/A
2030-06-09
Corvus Pharmaceuticals Inc. CRVS Thompson Peter A.
Director
10% Owner
15,000 $0 6,782,584
(Direct)
View
2020-03-19
Option Award
2020-03-23
5:28 pm
N/A
2030-03-19
Corvus Pharmaceuticals Inc. CRVS Thompson Peter A.
Director
10% Owner
15,000 $0 6,782,584
(Direct)
View
2020-01-23
Equity Swap
2020-01-24
6:44 pm
N/A
N/A
Synthorx Inc. THOR Thompson Peter A.
Director
10% Owner
5,316,355 $68 0
(Indirect)
View
2020-01-23
Disposition
2020-01-24
6:44 pm
N/A
2028-12-05
Synthorx Inc. THOR Thompson Peter A.
Director
10% Owner
30,000 $57 0
(Direct)
View
2020-01-23
Disposition
2020-01-24
6:44 pm
N/A
2029-06-06
Synthorx Inc. THOR Thompson Peter A.
Director
10% Owner
15,335 $55.6 0
(Direct)
View
2020-01-02
Option Award
2020-01-06
8:00 pm
N/A
2030-01-01
ALPINE IMMUNE SCIENCES Inc ALPN Thompson Peter A.
Director
10% Owner
7,650 $0 7,650
(Direct)
View
2019-06-24
Conversion
2019-06-26
4:56 pm
N/A
N/A
Prevail Therapeutics Inc. PRVL Thompson Peter A.
Director
10% Owner
21,020,222 $0 13,822,463
(Indirect)
View
2019-06-20
Option Award
2019-06-24
4:05 pm
N/A
2029-06-20
Corvus Pharmaceuticals Inc. CRVS Thompson Peter A.
Director
10% Owner
15,000 $0 5,982,584
(Direct)
View
2019-06-19
Ownership
2019-06-19
6:34 pm
N/A
N/A
Prevail Therapeutics Inc. PRVL Thompson Peter A.
Director
10% Owner
0 $0 12,940,111
(Indirect)
View
2019-06-07
Option Award
2019-06-10
6:52 pm
N/A
2029-06-06
Synthorx Inc. THOR Thompson Peter A.
Director
10% Owner
15,335 $0 15,335
(Direct)
View
2019-01-02
Option Award
2019-01-04
4:01 pm
N/A
2029-01-01
ALPINE IMMUNE SCIENCES Inc ALPN Thompson Peter A.
Director
10% Owner
7,650 $0 7,650
(Direct)
View
Goto 0, 1, Next